Company Filing History:
Years Active: 2004-2009
Title: Innovations of Foyeke Opawale: Pioneering Pharmaceutical Advancements
Introduction
Foyeke Opawale, based in Raleigh, NC, is an accomplished inventor holding three patents that significantly contribute to the field of pharmaceuticals. His innovative work focuses primarily on the development of novel drug formulations that enhance therapeutic effectiveness.
Latest Patents
Foyeke's latest inventions include:
1. **Micro-particle fatty acid salt solid dosage formulations for therapeutic agents**: This patent outlines fatty acid salt particles designed with a size distribution between 1 and 1,000 microns in diameter. It discusses their application in pharmaceutical compositions, as well as methods for their production and usage.
2. **Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith**: This patent describes innovative pharmaceutical compositions that comprise a drug and/or a drug-oligomer conjugate, complemented by fatty acid and bile salt components. It details methods for treating diseases using these compositions, aiming to improve the efficacy of therapeutic agents.
Career Highlights
Foyeke has garnered experience and expertise while working at notable companies such as Nobex Corporation and Biocon Limited. His tenure at these organizations has allowed him to refine his skills in pharmaceutical innovation, directly contributing to the evolution of drug delivery systems.
Collaborations
Throughout his career, Foyeke has collaborated with learned colleagues, including Richard Soltero and Nnochiri Ekwuribe. These partnerships have furthered his research and development efforts, driving forward the creation of impactful pharmaceutical solutions.
Conclusion
Foyeke Opawale's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a forward-thinking inventor. His work has the potential to advance therapeutic techniques and improve patient outcomes, marking him as a significant figure in the realm of pharmaceutical innovations.